SUPRATHERAPEUTIC PT-INR IN A PATIENT ON CRIZOTINIB FOR STAGE IV NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Ibrahim, Samer
Boden, Brian
Spyris, Konstadinos
机构：
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.586
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：593A / 593A
页数：1
相关论文
共 50 条
  • [31] Our experience with crizotinib in the treatment of non-small cell lung cancer
    Aksel, Nimet
    Gayaf, Mine
    Ari, Gulsum
    Akyol, Murat
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [32] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [33] Clinical use of crizotinib for the treatment of non-small cell lung cancer
    Roberts, Patrick J.
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 91 - 101
  • [34] Crizotinib In Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Curran, Monique P.
    DRUGS, 2012, 72 (01) : 99 - 107
  • [35] Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive stage IV non-small cell lung cancer.
    Din, Ahmed M. Mohi Ei.
    Rasmy, Ayman Ahamd
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
    Rebekah Park
    James W. Shaw
    Alix Korn
    Jacob McAuliffe
    Journal of Cancer Survivorship, 2020, 14 : 363 - 376
  • [37] The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
    Park, Rebekah
    Shaw, James W.
    Korn, Alix
    McAuliffe, Jacob
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (03) : 363 - 376
  • [38] PROVINCE-WIDE ANALYSIS OF PATIENT REPORTED OUTCOMES FOR STAGE IV NON-SMALL CELL LUNG CANCER
    Tjong, Michael C.
    Doherty, Mark
    Tan, Hendrick
    Chan, Wing C.
    Zhao, Haoyu
    Hallet, Julie
    Darling, Gail
    Kidane, Biniam
    Wright, Frances C.
    Mahar, Alyson
    Davis, Laura E.
    Delibasic, Victoria
    Parmar, Ambika
    Mittmann, Nicole
    Coburn, Natalie G.
    Louie, Alexander V.
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S14 - S15
  • [39] What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?
    Moro-Sibilot, D.
    Pluquet, E.
    Zalcman, G.
    Brechot, J. -M.
    Souquet, P. -J.
    Debieuvre, D.
    Morin, F.
    Morere, J. -F.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S120 - S124
  • [40] Perioperative chemoimmunotherapy in a patient with stage IIIB non-small cell lung cancer
    Liang, Hengrui
    Deng, Hongsheng
    Liang, Wenhua
    Guo, Kai
    Gao, Ziqing
    Wiesel, Ory
    Flores, Raja M.
    Song, Kimberly
    Redwan, Bassam
    Migliore, Marcello
    Li, Shuben
    Yin, Weiqiang
    He, Jianxing
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
12345